ロード中...
Chelation for autism spectrum disorder (ASD)
BACKGROUND: It has been suggested that the severity of autism spectrum disorder (ASD) symptoms is positively correlated with the level of circulating or stored toxic metals, and that excretion of these heavy metals, brought about by the use of pharmaceutical chelating agents, results in improved sym...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2015
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457964/ https://ncbi.nlm.nih.gov/pubmed/26114777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010766.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|